The association of serum potassium level with left ventricular mass in patients with primary aldosteronism

European Journal of Clinical Investigation

Volumn 41, Issue 7, 2011, Pages 743-750

  Lin, Yen Hung ^a   Wang, Shuo Meng ^a   Wu, Vin Cent ^a   Lee, Jen Kuang ^a   Kuo, Chin Chi ^a   Yen, Ruoh Fang ^a   Liu, Kao Lang ^a   Huang, Kuo How ^a   Chueh, Shih Chieh ^a,b   Wang, Wei Jie ^c   Lin, Lian Yu ^a   Chien, Kuo Long ^a,d   Ho, Yi Lwun ^a   Chen, Ming Fong ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Aldosterone; Diastolic function; Left ventricular mass; Potassium; Primary aldosteronism

Indexed keywords

ALDOSTERONE; CREATININE; POTASSIUM;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERALDOSTERONISM; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

ADULT; AGED; ALDOSTERONE; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIASTOLE; FEMALE; HEART VENTRICLES; HUMANS; HYPERALDOSTERONISM; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POTASSIUM; PROSPECTIVE STUDIES;

EID: 79958749845     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02462.x     Document Type: Article

References (39)

1. Young WF Jr. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003;144:2208-13.
2. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002;40:897-902.
3. Gaddam KK, Pimenta E, Husain S, Calhoun DA. Aldosterone and cardiovascular disease. Curr Probl Cardiol 2009;34:51-84.
4. Rossi GP, Seccia TM, Pessina AC. Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 2008;21:447-54.
5. Rossi GP. Prevalence and diagnosis of primary aldosteronism. Curr Hypertens Rep 2010;12:342-8.
6. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997;95:1471-8.
7. Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996;27:1039-45.
8. Matsumura K, Fujii K, Oniki H, Oka M, Iida M. Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens 2006;19:13-8.
9. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997;20:85-90.
10. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-8.
11. Coca SG, Perazella MA, Buller GK. The cardiovascular implications of hypokalemia. Am J Kidney Dis 2005;45:233-47.
12. Tepper SH, Anderson PA, Mergner WJ. Recovery of heart tissue following focal injury induced by dietary restriction of potassium. Pathol Res Pract 1990;186:265-82.
13. Mc AP. Myocardial changes occurring in potassium deficiency. Br Heart J 1955;17:5-14.
14. Fitzovich DE, Hamaguchi M, Tull WB, Young DB. Chronic hypokalemia and the left ventricular responses to epinephrine and preload. J Am Coll Cardiol 1991;18:1105-11.
15. Srivastava TN, Young DB. Impairment of cardiac function by moderate potassium depletion. J Card Fail 1995;1:195-200.
16. Xie Z, Liu J, Malhotra D, Sheridan T, Periyasamy SM, Shapiro JI. Effects of hypokalemia on cardiac growth. Ren Fail 2000;22:561-72.
17. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab 2009;94:1125-30.
18. Chang LC, Huang KC, Wu YW, Kao HL, Chen CL, Lai LP et al. The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc 2009;108:353-66.
19. Wu VC, Chang HW, Liu KL, Lin YH, Chueh SC, Lin WC et al. Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests. Am J Hypertens 2009;22:821-7.
20. Wu VC, Chueh SC, Chang HW, Lin WC, Liu KL, Li HY et al. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. QJM 2008;101:13-22.
21. Lin YH, Huang KH, Lee JK, Wang SM, Yen RF, Wu VC et al. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy. J Renin Angiotensin Aldosterone Syst 2010;doi: [Epub ahead of print].
22. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
23. Watt GC, Harrap SB, Foy CJ, Holton DW, Edwards HV, Davidson HR et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992;10:473-82.
24. Rossi GP, Di Bello V, Ganzaroli C, Sacchetto A, Cesari M, Bertini A et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002;40:23-7.
25. Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH et al. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 2009;54:665-73.
26. Wu VC, Kuo CC, Chang HW, Tsai CT, Lin CY, Lin LY et al. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity. Clin Chim Acta 2010;411:657-63.
27. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8.
28. Ayus JC, Go AS, Valderrabano F, Verde E, de Vinuesa SG, Achinger SG et al. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10g/dL. Kidney Int 2005;68:788-95.
29. Horita Y, Inenaga T, Nakahama H, Ishibashi-Ueda H, Kawano Y, Nakamura S et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis 2001;37:884-9.
30. Weber KT, Brilla CG, Janicki JS, Reddy HK, Campbell SE. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol 1991;86(Suppl 3):25-31.
31. Tsioufis C, Tsiachris D, Dimitriadis K, Stougiannos P, Missovoulos P, Kakkavas A et al. Myocardial and aortic stiffening in the early course of primary aldosteronism. Clin Cardiol 2008;31:431-6.
32. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52.
33. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
34. Shapiro JI, Kennedy DJ, Malhotra D, Xie M, Vetteth S. Hypokalemia potentiates ouabain's effect on calcium cycling and cardiac growth. Cell Mol Biol (Noisy-le-grand) 2006;52:87-91.
35. Wang Q, Domenighetti AA, Pedrazzini T, Burnier M. Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice. Hypertension 2005;46:547-54.
36. Rodriguez L, Garcia M, Ares M, Griffin BP, Nakatani S, Thomas JD. Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J 1996;131:982-7.
37. Yoshihara F, Nishikimi T, Yoshitomi Y, Nakasone I, Abe H, Matsuoka H et al. Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension. Am J Hypertens 1996;9:523-8.
38. Okoshi MP, Yan X, Okoshi K, Nakayama M, Schuldt AJ, O'Connell TD et al. Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 2004;10:511-8.
39. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007;50:911-8.